Source: Caritas St. Elizabeth's Medical Center
Posted: October 24, 2006
Summary:
Encouraging 12-month results from a Phase I trial investigating the injection of adult bone marrow stem cells into the hearts of patients with severe coronary artery disease will be presented for the first time. The therapy involves injecting patients with a protein that helps to release stem cells from the patient's bone marrow into the blood stream. The stem cells are gathered, selected and then injected into areas of the heart that have been damaged due to an insufficient supply of oxygen-rich blood. The data provide evidence that this therapy is well tolerated at this stage and that larger, Phase II clinical trials can continue in humans.
Commentary: Hopefully Phase II clinical trials to this new stem cell treatment will also be successful and become a widespread, standard treatment for patients with severe coronary artery disease.
No comments:
Post a Comment